{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T14:26:42Z","timestamp":1793111202791,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R41AG071265-01A1"],"award-info":[{"award-number":["1R41AG071265-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009645","name":"National Academy of Medicine","doi-asserted-by":"publisher","award":["2000012740"],"award-info":[{"award-number":["2000012740"]}],"id":[{"id":"10.13039\/100009645","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.atherosclerosis.2025.119217","type":"journal-article","created":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T02:11:47Z","timestamp":1746411107000},"page":"119217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Selective removal of 7-ketocholesterol by a novel atherosclerosis therapeutic candidate reverts foam cells to a macrophage-like phenotype"],"prefix":"10.1016","volume":"409","author":[{"given":"Prerna","family":"Bhargava","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren","family":"Dinh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadzai","family":"Teramayi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Silberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noa","family":"Petler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia M.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keivan","family":"Sadrerafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6361-9466","authenticated-orcid":false,"given":"Daniel M.","family":"Clemens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1997-983X","authenticated-orcid":false,"given":"Matthew S.","family":"O'Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.atherosclerosis.2025.119217_bib1","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3390\/biom8030080","article-title":"Research progress on the relationship between atherosclerosis and inflammation","volume":"8","author":"Zhu","year":"2018","journal-title":"Biomolecules"},{"key":"10.1016\/j.atherosclerosis.2025.119217_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101380","article-title":"7-Ketocholesterol in disease and aging","volume":"29","author":"Anderson","year":"2020","journal-title":"Redox Biol"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2025.119217_bib3","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1161\/CIRCRESAHA.115.304666","article-title":"CD36-dependent 7-ketocholesterol accumulation in macrophages mediates progression of atherosclerosis in response to chronic air pollution exposure","volume":"115","author":"Rao","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2025.119217_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2019.113648","article-title":"7-Ketocholesterol and 7\u03b2-hydroxycholesterol: in vitro and animal models used to characterize their activities and to identify molecules preventing their toxicity","volume":"173","author":"Vejux","year":"2020","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.119217_bib5","doi-asserted-by":"crossref","first-page":"R40","DOI":"10.1530\/REM-22-0005","article-title":"Sources of 7-ketocholesterol, metabolism and inactivation strategies: food and biomedical applications","volume":"2022","author":"Ghzaiel","year":"2022","journal-title":"Redox Experimental Medicine"},{"issue":"46","key":"10.1016\/j.atherosclerosis.2025.119217_bib6","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.12578","article-title":"7-Ketocholesterol induces ATM\/ATR, Chk1\/Chk2, PI3K\/Akt signalings, cytotoxicity and IL-8 production in endothelial cells","volume":"7","author":"Chang","year":"2016","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2025.119217_bib7","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.yexmp.2018.01.008","article-title":"Potential of anti-inflammatory agents for treatment of atherosclerosis","volume":"104","author":"Chistiakov","year":"2018","journal-title":"Exp Mol Pathol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.119217_bib8","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s12944-019-1156-7","article-title":"CPT1a gene expression reverses the inflammatory and anti-phagocytic effect of 7-ketocholesterol in RAW264.7 macrophages","volume":"18","author":"Calle","year":"2019","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.atherosclerosis.2025.119217_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/152786","article-title":"LOX-1, OxLDL, and atherosclerosis","volume":"2013","author":"Pirillo","year":"2013","journal-title":"Mediat Inflamm"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2025.119217_bib10","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1083\/jcb.82.3.597","article-title":"Reversible accumulation of cholsteryl esters in macrophages incubated with acetylated lipoproteins","volume":"82","author":"Brown","year":"1979","journal-title":"J Cell Biol"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2025.119217_bib11","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.cmet.2011.03.023","article-title":"Autophagy regulates cholesterol efflux from macrophage foam cells via lysosomal acid lipase","volume":"13","author":"Ouimet","year":"2011","journal-title":"Cell Metab"},{"key":"10.1016\/j.atherosclerosis.2025.119217_bib12","first-page":"1","article-title":"Reactive oxygen species-induced lipid peroxidation in apoptosis, autophagy, and ferroptosis","volume":"2019","author":"Su","year":"2019","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.119217_bib13","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3390\/ijms19010092","article-title":"The phagocytic function of macrophage-enforcing innate immunity and tissue homeostasis","volume":"19","author":"Hirayama","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2025.119217_bib14","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1253\/circj.CJ-16-0924","article-title":"Macrophage apoptosis and efferocytosis in the pathogenesis of atherosclerosis","volume":"80","author":"Linton","year":"2016","journal-title":"Circ J"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2025.119217_bib15","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/S0022-2275(20)31498-X","article-title":"Pivotal role of ABCA1 in reverse cholesterol transport influencing HDL levels and susceptibility to atherosclerosis","volume":"42","author":"Attie","year":"2001","journal-title":"JLR (J Lipid Res)"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.119217_bib16","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.atherosclerosis.2008.04.011","article-title":"Adiponectin reduces lipid accumulation in macrophage foam cells","volume":"202","author":"Tian","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2025.119217_bib17","first-page":"12097","volume":"vol. 97","author":"Venkateswaran","year":"2000"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2025.119217_bib18","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0092-8674(00)81574-3","article-title":"Oxidized LDL regulates macrophage gene expression through ligand activation of PPAR\u03b3","volume":"93","author":"Nagy","year":"1998","journal-title":"Cell"},{"issue":"6662","key":"10.1016\/j.atherosclerosis.2025.119217_bib19","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/34178","article-title":"The peroxisome proliferator-activated receptor-\u03b3 is a negative regulator of macrophage activation","volume":"391","author":"Ricote","year":"1998","journal-title":"Nature"},{"issue":"15","key":"10.1016\/j.atherosclerosis.2025.119217_bib20","doi-asserted-by":"crossref","first-page":"9852","DOI":"10.1074\/jbc.M703318200","article-title":"Oxidized low density lipoprotein activates peroxisome proliferator-activated Receptor-\u03b1 (PPAR\u03b1) and PPAR\u03b3 through MAPK-Dependent COX-2 expression in macrophages","volume":"283","author":"Taketa","year":"2008","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2025.119217_bib21","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/jps.20047","article-title":"Self-association of cyclodextrins and Cyclodextrin complexes","volume":"93","author":"Loftsson","year":"2004","journal-title":"J Pharmaceut Sci"},{"issue":"120522","key":"10.1016\/j.atherosclerosis.2025.119217_bib22","article-title":"Cyclodextrin dimers: a versatile approach to optimizing encapsulation and their application to therapeutic extraction of toxic oxysterols","volume":"606","author":"Anderson","year":"2021","journal-title":"Int J Pharm"},{"issue":"44","key":"10.1016\/j.atherosclerosis.2025.119217_bib23","doi-asserted-by":"crossref","first-page":"27450","DOI":"10.1074\/jbc.271.44.27450","article-title":"Hydroxypropyl-\u03b2-cyclodextrin-mediated efflux of 7-Ketocholesterol from macrophage foam cells","volume":"271","author":"Kritharides","year":"1996","journal-title":"J Biol Chem"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2025.119217_bib24","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1161\/CIRCRESAHA.117.311049","article-title":"Association of plasma 7-Ketocholesterol with cardiovascular outcomes and total mortality in patients with coronary artery disease","volume":"120","author":"Song","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2025.119217_bib25","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.redox.2017.10.020","article-title":"Lipidomics reveals accumulation of the oxidized cholesterol in erythrocytes of heart failure patients","volume":"14","author":"Tang","year":"2018","journal-title":"Redox Biol"},{"issue":"22","key":"10.1016\/j.atherosclerosis.2025.119217_bib26","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1136\/heartjnl-2016-310914","article-title":"Plasma 7-ketocholesterol levels and the risk of incident cardiovascular events","volume":"103","author":"Wang","year":"2017","journal-title":"Heart"},{"key":"10.1016\/j.atherosclerosis.2025.119217_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2023.121360","article-title":"Addressing the complexities in measuring cyclodextrin-sterol binding constants: a multidimensional study","volume":"323","author":"Anderson","year":"2024","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.atherosclerosis.2025.119217_bib28","series-title":"Selective removal of 7KC by a novel atherosclerosis therapeutic candidate reverts foam cells to a macrophage-like phenotype (p. 2023.10.23.563623)","author":"Bhargava","year":"2023"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2025.119217_bib29","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/cyto.a.20867","article-title":"Rationale for the real-time and dynamic cell death assays using propidium iodide","volume":"77A","author":"Zhao","year":"2010","journal-title":"Cytometry A"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2025.119217_bib30","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3390\/biomedicines10020329","article-title":"Mitochondrial transplantation enhances phagocytic function and decreases lipid accumulation in foam cell macrophages","volume":"10","author":"J\u00e1tiva","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.atherosclerosis.2025.119217_bib31","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.biochi.2018.07.009","article-title":"Induction of peroxisomal changes in oligodendrocytes treated with 7-ketocholesterol: attenuation by \u03b1-tocopherol","volume":"153","author":"Nury","year":"2018","journal-title":"Biochimie"},{"key":"10.1016\/j.atherosclerosis.2025.119217_bib32","series-title":"Implication of oxysterols and phytosterols in aging and human diseases","first-page":"163","article-title":"Impact of oxysterols in age-related disorders and strategies to alleviate adverse effects","author":"Ghosh","year":"2024"},{"key":"10.1016\/j.atherosclerosis.2025.119217_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.crbiot.2024.100195","volume":"7","author":"Nury","year":"2024","journal-title":"Current Research in Biotechnology"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2025.119217_bib34","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/tra.12576","article-title":"7-Ketocholesterol impairs phagocytosis and efferocytosis via dysregulation of phosphatidylinositol 4,5-bisphosphate","volume":"19","author":"Lu","year":"2018","journal-title":"Traffic"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2025.119217_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/s44161-022-00023-x","article-title":"The pleiotropic benefits of statins include the ability to reduce CD47 and amplify the effect of pro-efferocytic therapies in atherosclerosis","volume":"1","author":"Jarr","year":"2022","journal-title":"Nature Cardiovascular Research"},{"issue":"7614","key":"10.1016\/j.atherosclerosis.2025.119217_bib36","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/nature18935","article-title":"CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis","volume":"536","author":"Kojima","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2025.119217_bib37","series-title":"General methods in biomarker research and their applications","first-page":"223","article-title":"Macrophage inflammatory Protein-1 alpha (MIP-1 alpha)\/CCL3: as a biomarker","author":"Bhavsar","year":"2015"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2025.119217_bib38","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1242\/jcs.182097","article-title":"Oxidized LDL induces FAK-Dependent RSK signaling to drive NF-\u03baB activation and VCAM-1 expression","volume":"129","author":"Yurdagul","year":"2016","journal-title":"J Cell Sci"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.119217_bib39","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ijcard.2013.12.170","article-title":"Association of interleukin 8 with myocardial infarction: results from the Stockholm heart epidemiology program","volume":"172","author":"Vel\u00e1squez","year":"2014","journal-title":"Int J Cardiol"},{"issue":"23","key":"10.1016\/j.atherosclerosis.2025.119217_bib40","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.237271","article-title":"High-density lipoprotein or cyclodextrin extraction of cholesterol from aggregated LDL reduces foam cell formation","volume":"132","author":"Singh","year":"2019","journal-title":"J Cell Sci"},{"issue":"333","key":"10.1016\/j.atherosclerosis.2025.119217_bib41","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad6100","article-title":"Cyclodextrin promotes atherosclerosis regression via macrophage reprogramming","volume":"8","author":"Zimmer","year":"2016","journal-title":"Sci Transl Med"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2025.119217_bib42","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00395-020-00829-5","article-title":"Mouse models of atherosclerosis and their suitability for the study of myocardial infarction","volume":"115","author":"Golforoush","year":"2020","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.atherosclerosis.2025.119217_bib43","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.artres.2017.08.002","article-title":"Sex differences in the LDL receptor knockout mouse model of atherosclerosis","volume":"20","author":"Mansukhani","year":"2017","journal-title":"Artery Research"},{"key":"10.1016\/j.atherosclerosis.2025.119217_bib44","series-title":"Atherosclerosis: methods and protocols","first-page":"3","article-title":"Atherosclerosis: pathogenesis pathogenesis and key cellular ProcessesCellular processes, current and emerging TherapiesTherapies, key challenges, and future research directions","author":"Chan","year":"2022"},{"key":"10.1016\/j.atherosclerosis.2025.119217_bib45","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12944-016-0402-5","article-title":"Mouse models of atherosclerosis: a historical perspective and recent advances","volume":"16","author":"Lee","year":"2017","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.atherosclerosis.2025.119217_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2024.118562","article-title":"HDL, reverse cholesterol transport, and atherosclerosis: unravelling the complexity or adding to the confusion?","volume":"397","author":"Parini","year":"2024","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2025.119217_bib47","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1016\/j.atherosclerosis.2019.06.160","article-title":"Treatment with 2-Hydroxypropyl-\u0392-Cyclodextrin induces macrophage cholesterol efflux in vitro but does not induce lesion regression in apoe knockout mice in vivo","volume":"287","author":"Zhang","year":"2019","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2025.119217_bib48","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s10557-021-07237-4","article-title":"K-80003 inhibition of macrophage apoptosis and necrotic core development in atherosclerotic vulnerable plaques","volume":"36","author":"Wang","year":"2022","journal-title":"Cardiovasc Drugs Ther"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915025001157?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915025001157?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T11:01:20Z","timestamp":1763204480000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915025001157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":48,"alternative-id":["S0021915025001157"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2025.119217","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.10.23.563623","asserted-by":"object"}]},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selective removal of 7-ketocholesterol by a novel atherosclerosis therapeutic candidate reverts foam cells to a macrophage-like phenotype","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2025.119217","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"119217"}}